Puma (PBYI) announced that its Marketing Authorization Application for neratinib has been validated by the European Medicines Agency.
- Barrons.com•2 days ago
Now that Medivation (MDVN) has agreed to be bought by Pfizer (PFE), Citigroup's Yigal Nochomovitz and Yang Huang argue that Ophthotech (OPHT), Puma Biotechnology (PBYI), Lexicon Pharmaceuticals (LXRX), ...
Puma Biotechnology, Inc. (PBYI)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||61.93 x 300|
|Ask||62.14 x 100|
|Day's Range||56.25 - 63.06|
|52wk Range||19.74 - 107.49|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-7.80|
|Avg Vol (3m)||683,840|
|Dividend & Yield||N/A (N/A)|